References
References
- Gschwend , JE , Fair , WR and Vieweg , J . 2000 . Radical cystectomy for invasive bladder cancer: contemporary results and remaining controversies . Eur. Urol. , 38 : 121 – 130 .
- Cheng L Weaver AL Leibovich BC et al. 2000 Predicting the survival of bladder carcinoma patients treated with radical cystectomy Cancer 88 2326 2332
- Wijkstrom H Norming U Lagerkvist M et al. 1998 Evaluation of clinical staging before cystectomy in transitional cell carcinoma: a long-term follow-up of 276 consecutive patients Br. J. Urol. 81 686 691
- Stenberg CN Yagoda A Scher HI et al. 1985 Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium J. Urol. 133 403 407
- Logothetis CJ Samuels ML Ogden S et al. 1985 Cyclophosphamide, doxorubicin and cisplatin chemotherapy for patients with locally advanced urothelial tumors with or without nodal metastases J. Urol. 134 460 464
- Logothetis CJ Johnson DE Chong C et al. 1988 Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update J. Clin. Oncol. 6 1590 1596
- Skinner DG Daniels JR Russel CA et al. 1991 The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial J. Urol. 145 459 467
- Freiha , F , Reese , J and Torti , FM . 1996 . A randomized trial of radical cystectomy versus partial cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer . J. Urol. , 155 : 495 – 500 .
- Igawa M Urakami S Shiina H et al. 1995 Long-term results with M-VAC for advanced urothelial cancer: high response rate and low survival in patients with a complete response Br. J. Urol. 76 321 324
- Miyake H Gohji K Hara I et al. 1999 Long-term results of neoadjuvant treatment with M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for locally invasive transitional cell carcinoma of the urothelium Int. J. Clin. Oncol. 4 32 35
- Loehrer PJ Sr. Einhorn LH Elson PJ et al. 1992 A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study J. Clin. Oncol. 10 1066 1073
- Logothetis CJ Dexeus FH Finn L et al. 1990 A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors J. Clin. Oncol. 8 1050 1055
- Gohji K Higuchi A Maruyama S et al. 1993 Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristin, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report Jpn J. Clin. Oncol. 23 291 298
- Gohji K Ono Y Takenaka A et al. 1999 Long-term follow-up results of a pilot phase II study of multidrug chemotherapy (MVP-CAB) in patients with advanced urothelial cancer Jpn J. Clin. Oncol. 29 204 208
- International Union Against Cancer 1997 TNM Classification of Malignant Tumors, John Wiley & Sons New York
- Mostofi FK Davis CJ Sesterhenn IA 1999 Histological Typing of Urinary Bladder Tumours, Springer Verlag Berlin
- Winquist E Kirchner TS Segal R et al. 2004 Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis J. Urol. 171 561 569
- Millikan R Dinney C Swanson D et al. 2001 Integrated therapy for locally advanced bladder cancer: final report of a randomized trail of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC J. Clin. Oncol. 19 4005 4013